Link to this page
Physician Data Query
Last uploaded:
August 28, 2024
Jump to:
| Preferred Name | valganciclovir | |
| Synonyms |
VGCV Valcyte |
|
| Definitions |
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2629" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2629" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000038289 |
|
| altLabel |
VGCV Valcyte
|
|
| Component of | ||
| cui |
C0969586 C0909381
|
|
| Date last modified |
2006-09-28
|
|
| definition |
A synthetic prodrug of ganciclovir, a nucleoside analogue of 2'-deoxyguanosine, with antiviral activity. After phosphorylation, valganciclovir is incorporated into DNA, resulting in inhibition of viral DNA polymerase, viral DNA synthesis, and viral replication. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C2629" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C2629" NCI Thesaurus)
|
|
| Legacy PDQ ID |
10899
|
|
| LT |
TRD
|
|
| NCI ID |
C2629
|
|
| notation |
CDR0000038289
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
valganciclovir
|
|
| tui |
T109 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping